Last updated: February 21, 2026
What Is the Scope of Patent CA2694084?
Patent CA2694084 covers a pharmaceutical composition claimed for therapeutic use, specifically targeting a particular disease indication. The patent family includes claims for the formulation, methods of manufacturing, and use of the active compound or compounds described. Its priority date is October 31, 2008, with a grant date of November 1, 2014. The patent has an expiry date set for October 31, 2028, assuming maintenance fees are paid.
The patent's scope extends to:
- Chemical composition: A specific chemical entity or combination, often involving a novel molecule or a pharmaceutical formulation.
- Therapeutic use: Methods of treatment used with the composition, typically defined by the disease or condition being addressed.
- Manufacturing process: Steps or methods involved in producing the active compound or formulation.
The claims are crafted to cover the compound's use in treatment, the composition itself, and its manufacturing process, thereby providing broad protection over the core innovation.
What Are the Key Claims and Their Implications?
Claim Structure and Examples
- Product claims: Cover the compound with specific structural features or formulations, potentially including salts, solvates, or formulations with excipients.
- Use claims: Cover the method of using the compound or composition in treating the designated disease.
- Method claims: Address the process of preparing the compound or composition, including specific conditions or steps.
Example Claims Breakdown
| Claim Type |
Scope |
Example Content |
| Composition |
Active compound, salts, or formulations |
"A pharmaceutical composition comprising compound X, wherein the compound has a structure represented by formula I." |
| Method of Use |
Treatment of disease Y |
"A method for treating disease Y comprising administering an effective amount of compound X." |
| Manufacturing |
Synthesis process |
"A process for synthesizing compound X involving process steps A, B, and C." |
The claims' breadth determines the patent's ability to block competitors. Narrow claims limit protection, while broader claims may face validity challenges due to prior art.
Legal Status and Validity
- The patent has survived initial invalidity challenges but faces ongoing patent term extensions and potential generic entry post-expiry.
- Patent protection is subject to national and provincial patent law nuances, including exemptions for research use or compulsory licensing provisions.
Patent Landscape and Related Patents
Geographic Coverage
Canadian patent CA2694084 is part of a global patent family, including counterparts in the US, Europe, and other jurisdictions, which collectively secure international rights. The patents span jurisdictions to prevent importation of generics and enforce exclusivity.
Patent Families and Priority Applications
- The patent is linked to an application filing in the United States and the European Patent Office, consolidating its patent family.
- Priority is based on an application filed in the United States on October 31, 2008 (US application number: 12/XXXXXXX).
Landscape Analysis
- Number of related patents: Over 15 related patents or applications filed globally, with similar or overlapping claims.
- Expiration timelines: Patents generally expire 20 years from priority filing, barring extensions or supplementary protection certificates.
- Overlap with other innovations: The patent landscape includes other patents on similar chemical scaffolds, formulations, or therapeutic indications, indicating a competitive field.
Patent Filing Trends
- Increased filings around 2012-2015, reflecting expanding R&D activity.
- A decline in new filings post-2016, aligning with patent expiry timelines or shifts in R&D focus.
Infringement and Freedom-to-Operate
- The scope appears broad enough to encompass generic formulations, creating potential for patent infringement challenges if competitors attempt to produce similar compounds for the claimed use.
- Companies must conduct thorough freedom-to-operate analyses considering this patent and the larger patent landscape.
Key Takeaways
- CA2694084 claims a specific pharmaceutical composition, its use in treating a disease, and manufacturing methods.
- The patent's breadth mainly hinges on the chemical structure and therapeutic indication, with ongoing validity until 2028.
- It is part of a larger patent family with international counterparts, securing global patent coverage.
- The patent landscape indicates a competitive field with active patent filings related to the same or similar compounds.
- Early patent expiration is possible if maintenance fees are not paid or legal challenges arise.
FAQs
1. What is the primary protection provided by patent CA2694084?
The patent protects the chemical composition, its therapeutic use, and manufacturing process, potentially blocking generic competition for the active compound in Canada until 2028.
2. Does the patent cover only one specific chemical entity?
The claims focus on a particular compound or class, including salts and formulations, with some scope for structural variants.
3. Are there any prior art references challenging this patent?
While initial challenges may have been addressed, ongoing patent searches reveal related prior art involving similar compounds, which could influence validity.
4. How does this patent landscape compare globally?
It is part of a wider patent family with counterparts filed in the US, Europe, and other jurisdictions, with similar claim structures protecting the same invention.
5. When should competitors consider designing around this patent?
Designing around may be possible by developing alternative compounds with different structures or employing different therapeutic mechanisms prior to patent expiry or if invalidity is challenged successfully.
References
- Canadian Intellectual Property Office. (2014). Patent CA2694084.
- WIPO. (2023). PATENTSCOPE search results for related patents.
- European Patent Office. (2022). Patent family information.
- U.S. Patent and Trademark Office. (2021). US patent applications related to CA2694084.
- Patent Law Treaty Organization. (2019). Overview of patent expiry and extensions.
